{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T18:31:46Z","timestamp":1672684306887},"reference-count":41,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["U19 AI062629"],"award-info":[{"award-number":["U19 AI062629"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"OMRF J. Donald Capra Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.01.040","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T14:01:59Z","timestamp":1360764119000},"page":"1856-1863","source":"Crossref","is-referenced-by-count":3,"title":["Stochastic humoral immunity to Bacillus anthracis protective antigen: Identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization"],"prefix":"10.1016","volume":"31","author":[{"given":"Eric K.","family":"Dumas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Darise","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.01.040_bib0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2013.01.040_bib0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"November (6860)","key":"10.1016\/j.vaccine.2013.01.040_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"issue":"April (9)","key":"10.1016\/j.vaccine.2013.01.040_bib0020","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2013.01.040_bib0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"Klimpel","year":"1994","journal-title":"Mol Microbiol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2013.01.040_bib0030","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.01.040_bib0035","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2013.01.040_bib0040","first-page":"144","article-title":"Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production","volume":"35","author":"Belton","year":"1954","journal-title":"Br J Exp Pathol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2013.01.040_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","article-title":"Current status of immunization against anthrax: old vaccines may be here to stay for a while","volume":"13","author":"Turnbull","year":"2000","journal-title":"Curr Opin Infect Dis"},{"issue":"January","key":"10.1016\/j.vaccine.2013.01.040_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/JB.85.1.230-236.1963","article-title":"Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man","volume":"85","author":"Puziss","year":"1963","journal-title":"J Bacteriol"},{"issue":"August (33)","key":"10.1016\/j.vaccine.2013.01.040_bib0055","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.vaccine.2008.05.068","article-title":"An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals","volume":"26","author":"Hewetson","year":"2008","journal-title":"Vaccine"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2013.01.040_bib0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/653495","article-title":"Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge","volume":"202","author":"Crowe","year":"2010","journal-title":"J Infect Dis"},{"issue":"July (RR-6)","key":"10.1016\/j.vaccine.2013.01.040_bib0065","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2013.01.040_bib0070","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.vaccine.2006.01.054","article-title":"Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series","volume":"24","author":"Pittman","year":"2006","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.01.040_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CDLI.12.6.713-721.2005","article-title":"Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis","volume":"12","author":"Pittman","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2013.01.040_bib0080","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.vaccine.2011.03.011","article-title":"Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity","volume":"29","author":"Crowe","year":"2011","journal-title":"Vaccine"},{"issue":"August (33\/34)","key":"10.1016\/j.vaccine.2013.01.040_bib0085","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2013.01.040_bib0090","doi-asserted-by":"crossref","first-page":"e13849","DOI":"10.1371\/journal.pone.0013849","article-title":"Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults","volume":"5","author":"Brown","year":"2010","journal-title":"PLoS ONE"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2013.01.040_bib0095","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.181.8.5785","article-title":"Effect of CpG oligonucleotides on vaccine-induced B cell memory","volume":"181","author":"Tross","year":"2008","journal-title":"J Immunol"},{"issue":"July (21\/22)","key":"10.1016\/j.vaccine.2013.01.040_bib0100","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"issue":"September (2\/3)","key":"10.1016\/j.vaccine.2013.01.040_bib0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0264-410X(00)00174-2","article-title":"Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans","volume":"19","author":"Pittman","year":"2000","journal-title":"Vaccine"},{"issue":"October (13)","key":"10.1016\/j.vaccine.2013.01.040_bib0110","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2013.01.040_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/infdis\/jir268","article-title":"Common SNPs\/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans","volume":"204","author":"Haralambieva","year":"2011","journal-title":"J Infect Dis"},{"issue":"November (48)","key":"10.1016\/j.vaccine.2013.01.040_bib0120","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1016\/j.vaccine.2011.09.043","article-title":"Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"issue":"October (45)","key":"10.1016\/j.vaccine.2013.01.040_bib0125","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1016\/j.vaccine.2011.08.083","article-title":"Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"issue":"September (5894)","key":"10.1016\/j.vaccine.2013.01.040_bib0130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1161121","article-title":"Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection","volume":"321","author":"Santiago","year":"2008","journal-title":"Science"},{"issue":"September (9338)","key":"10.1016\/j.vaccine.2013.01.040_bib0135","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins","volume":"360","author":"Hohler","year":"2002","journal-title":"Lancet"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.01.040_bib0140","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1462-5822.2005.00539.x","article-title":"Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity","volume":"7","author":"Voth","year":"2005","journal-title":"Cell Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.01.040_bib0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00788-08","article-title":"Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies","volume":"77","author":"Nguyen","year":"2009","journal-title":"Infect Immun"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.01.040_bib0150","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/IAI.00749-09","article-title":"The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes","volume":"77","author":"Nguyen","year":"2009","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.01.040_bib0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-3083.1994.tb03413.x","article-title":"Basic amino acids predominate in the sequential autoantigenic determinants of the small nuclear 70K ribonucleoprotein","volume":"39","author":"James","year":"1994","journal-title":"Scand J Immunol"},{"issue":"June (28)","key":"10.1016\/j.vaccine.2013.01.040_bib0160","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.vaccine.2012.03.002","article-title":"Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization","volume":"30","author":"Smith","year":"2012","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.01.040_bib0165","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/IAI.00150-06","article-title":"A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1","volume":"74","author":"Rivera","year":"2006","journal-title":"Infect Immun"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2013.01.040_bib0170","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.bbrc.2006.01.080","article-title":"The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope","volume":"341","author":"Zhang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.01.040_bib0175","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00015-08","article-title":"Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background","volume":"15","author":"Abboud","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.01.040_bib0180","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1128\/IAI.00117-09","article-title":"Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen","volume":"77","author":"Kelly-Cirino","year":"2009","journal-title":"Infect Immun"},{"issue":"June (10)","key":"10.1016\/j.vaccine.2013.01.040_bib0185","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.molimm.2008.12.031","article-title":"Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis","volume":"46","author":"Kaur","year":"2009","journal-title":"Mol Immunol"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2013.01.040_bib0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1574-695X.2006.00114.x","article-title":"Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen","volume":"47","author":"Gubbins","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.01.040_bib0195","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/IAI.00358-09","article-title":"Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect Immun"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2013.01.040_bib0200","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1001749","article-title":"A synthetic peptide vaccine directed against the 2ss2-2ss3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax","volume":"185","author":"Oscherwitz","year":"2010","journal-title":"J Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2013.01.040_bib0205","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.4049\/jimmunol.1102190","article-title":"Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire","volume":"188","author":"Kwok","year":"2012","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:06:18Z","timestamp":1595405178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13001084"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}